August 2026

Papyrus Australia has expanded its TBS contract for an additional sample run after mixed trial results and secured a $200,000 unsecured loan with Irwin Biotech, advancing its capital raising efforts with L39 Capital.

Waterco Limited delivered a robust turnaround in FY26 with net profit after tax soaring 61.6% to $15.5 million on modest revenue growth. The company expanded its Swimart franchise, advanced manufacturing insourcing, and boosted dividends to 20 cents per share fully franked.

Jatcorp Limited's FY26 results show a 23% revenue increase to $38.9 million but a 41% larger loss attributable to owners. The company faces a material uncertainty over going concern despite improved statutory NPAT.

OncoSil Medical lifted revenues 44% in FY26 to $1.68 million and trimmed losses by 28% to $10.86 million, buoyed by key regulatory approvals including FDA HDE and Australian TGA listings. The company is poised for commercial launches in the US and Australia, with strong clinical data underpinning its growth.

Staude Capital Global Value Fund Limited posted a 47% drop in net profit after tax for FY2026 amid a 39% revenue decline, while adjusted pre-tax NTA rose 7%. The company declared a fully franked final dividend of 3.3 cents per share and completed a $18.2 million share purchase plan last year.

Alterity Therapeutics posted a 285% jump in revenue to A$1.72 million but also a 93% rise in net loss to A$23.4 million for FY2026. The company secured FDA alignment on a single pivotal Phase 3 trial for ATH434 in Multiple System Atrophy, setting the stage for trial start by year-end.

Tartana Minerals has lodged a cleansing prospectus to enable ASX quotation of over 129 million options linked to a $4.5 million placement, with exercise price set at 5.5 cents and expiry in April 2029.

Steamships Trading Company Limited saw a 14.3% revenue increase to K413.4 million in H1 2026, while net profit attributable to shareholders fell 12.2% to K21.8 million. Underlying profit rose 27.2% after adjusting for ERP expenses and insurance proceeds, with capital investment and cash flow both strengthening.

RooLife Group (ASX: RLG) reported a 268% jump in FY2026 revenue to nearly $10 million, driven by rapid growth in its own food and beverage products, including RLG Coffee in China. Despite this, the company recorded a $3.58 million net loss, weighed down by impairment charges and R&D investments in renewable energy.

Moonlight Resources Ltd (ASX: ML8) completed its first year as a listed entity, rapidly expanding its gold and copper exploration at the Clermont Project in Queensland. The company reported a net loss of $1.98 million for FY2026, reflecting active exploration and corporate growth following its December 2025 IPO.

Forrestania Resources secured near-unanimous shareholder approval for its acquisition of the Edna May Project and a $310 million capital raising, clearing the path to expand its gold footprint in Western Australia.

Finbar has completed settlement on a prime South Perth development site with an estimated end value of $402 million, adding scale and strategic depth to its $1.95 billion five-year pipeline.

Dominion Income Trust 1 (ASX:DN1) delivered a standout performance for the year ended 30 June 2026, generating a 7.32% net return and sharply higher distributions, significantly outperforming its benchmark.

Nanuk New World Fund delivered a robust 27.1% return for unhedged units and 36.1% for hedged units in FY2026, with net assets surpassing AUD 1.07 billion amid sustained investor demand.

Nanuk New World Fund posted robust gains in the 2026 financial year, with its hedged unit class surging 36.1% and unhedged units rising 27.1%, driven by a global equities portfolio focused on sustainability themes.

Argo Global Listed Infrastructure Limited has renewed its on-market buy-back facility for another year, allowing up to 9.4 million shares to be repurchased as part of ongoing capital management.

Boresight Ltd (ASX: BST) recorded a 46% increase in revenue to $6.38 million for FY26, driven by global sales expansion and strategic investments including an $8 million IPO. Despite this growth, the company posted a $6.66 million net loss, largely due to increased operational expenses and significant share-based payments.

BHP Group has updated its dividend announcement with South African Rand currency details and confirmed a fully franked USD 0.99 dividend for the six months ending June 2026. Shareholders can elect to receive payments in five currencies, with a Dividend Reinvestment Plan available at no discount.

SIV Capital posted a 244% increase in net loss for FY26 to $388,049 on a 33% revenue drop, with its legacy rental business winding down and ASX suspension ongoing. The company is pursuing a new transaction to regain listing approval.

Dexus has delivered a 37.0 cents per security distribution for FY26, matching guidance despite economic headwinds, while initiating a strategic review of infrastructure funds acquired in 2023 and forecasting lower earnings in FY27.

European Lithium has lodged the Scheme Booklet with ASIC for its proposed merger with Critical Metals Corp, advancing the regulatory process with a court hearing scheduled for mid-September.

Elixir Energy has marked FY26 with major progress in Queensland’s Taroom Trough, expanding contingent gas resources by 32% and securing a strategic $16.6 million capital raise led by Omega Oil and Gas. The company’s operational advances and government backing position it as a key player in Australia’s energy security landscape.

Nuchev has inked a consignment-based distribution deal to launch the Kuci women’s health probiotic range nationally through Chemist Warehouse, marking a strategic expansion into women’s health.

BKI Investment Company has expanded its risk disclosure, outlining significant market, income, operational, and regulatory risks that could influence its financial outcomes and shareholder dividends.